Mathew S - Search Results

1

Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease.

Li T, Surendran K, Zawaideh MA, Mathew S, Hruska KA. Li T, et al. Among authors: mathew s. Curr Opin Nephrol Hypertens. 2004 Jul;13(4):417-22. doi: 10.1097/01.mnh.0000133974.24935.fe. Curr Opin Nephrol Hypertens. 2004. PMID: 15199292 Review.

2

Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.

Mathew S, Davies M, Lund R, Saab G, Hruska KA. Mathew S, et al. Eur J Clin Invest. 2006 Aug;36 Suppl 2:43-50. doi: 10.1111/j.1365-2362.2006.01663.x. Eur J Clin Invest. 2006. PMID: 16884397

3

Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome.

Davies MR, Lund RJ, Mathew S, Hruska KA. Davies MR, et al. Among authors: mathew s. J Am Soc Nephrol. 2005 Apr;16(4):917-28. doi: 10.1681/ASN.2004100835. Epub 2005 Mar 2. J Am Soc Nephrol. 2005. PMID: 15743994

4

Bone morphogenetic proteins in vascular calcification.

Hruska KA, Mathew S, Saab G. Hruska KA, et al. Among authors: mathew s. Circ Res. 2005 Jul 22;97(2):105-14. doi: 10.1161/01.RES.00000175571.53833.6c. Circ Res. 2005. PMID: 16037577 Review.

5

Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.

Hruska KA, Mathew S, Davies MR, Lund RJ. Hruska KA, et al. Among authors: mathew s. Kidney Int Suppl. 2005 Dec;(99):S142-51. doi: 10.1111/j.1523-1755.2005.09926.x. Kidney Int Suppl. 2005. PMID: 16336568 Free article.

6

Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.

Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA. Mathew S, et al. J Am Soc Nephrol. 2007 Jan;18(1):122-30. doi: 10.1681/ASN.2006050490. Epub 2006 Dec 20. J Am Soc Nephrol. 2007. PMID: 17182886

7

Renal osteodystrophy, phosphate homeostasis, and vascular calcification.

Hruska KA, Saab G, Mathew S, Lund R. Hruska KA, et al. Among authors: mathew s. Semin Dial. 2007 Jul-Aug;20(4):309-15. doi: 10.1111/j.1525-139X.2007.00300.x. Semin Dial. 2007. PMID: 17635820 Review.

8

The mechanism of phosphorus as a cardiovascular risk factor in CKD.

Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA. Mathew S, et al. J Am Soc Nephrol. 2008 Jun;19(6):1092-105. doi: 10.1681/ASN.2007070760. Epub 2008 Apr 16. J Am Soc Nephrol. 2008. PMID: 18417722 Free PMC article.

9

Hyperphosphatemia of chronic kidney disease.

Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hruska KA, et al. Among authors: mathew s. Kidney Int. 2008 Jul;74(2):148-57. doi: 10.1038/ki.2008.130. Epub 2008 Apr 30. Kidney Int. 2008. PMID: 18449174 Free PMC article. Review.

10

The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

Hruska KA, Mathew S, Lund RJ, Memon I, Saab G. Hruska KA, et al. Among authors: mathew s. Semin Nephrol. 2009 Mar;29(2):156-65. doi: 10.1016/j.semnephrol.2009.01.008. Semin Nephrol. 2009. PMID: 19371806 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,750 results

Search Page

Filters